ELI LILLY & Co - 8-K Filing
Eli Lilly reports Q3 2026 revenue of $24.4 billion, up 39% YoY, and raises full-year guidance driven by Mounjaro and Zepbound demand. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $LLY
Read the full article at SEC EDGAR
Part of the story Cloudflare Shares Surge Following Strong Q3 Results and Raised Full-Year Guidance (85 articles)